Ritu Raman at MIT and Ryan Flynn at Boston Children's Hospital bring different scientific toolkits to bear on ALS research. Raman, a mechanical engineer, constructs living nerve and muscle tissues to model movement disorders, while Flynn, a chemical biologist, maps RNA on cell surfaces to understand cellular communication. Their complementary approaches converge through Google DeepMind's Co-Scientist platform.

When Raman turned to ALS research outside her usual domain, she faced months of sprawling literature. Co-Scientist compressed this research phase, helping her rapidly evaluate evidence against her tissue models and generate testable hypotheses ranked by feasibility and risk-reward trade-offs. The system surfaced promising leads involving cell surface interactions, an area requiring Flynn's RNA expertise.

This discovery catalyzed their collaboration, merging Raman's tissue engineering with Flynn's RNA mapping capabilities. Using Co-Scientist iteratively, they developed creative research pathways combining their distinct methodologies. Their current hunt focuses on identifying novel RNA-based mechanisms that could yield ALS therapeutics, potentially opening new drug development avenues for this devastating neurodegenerative disease.

This interdisciplinary approach demonstrates how AI-assisted tools can bridge traditionally separate scientific domains, accelerating discovery by connecting mechanical engineering perspectives with molecular biology insights in the fight against neurological disorders.